Each restricted stock unit represents a contingent right to receive one share of common stock of AMAG Pharmaceuticals, Inc. (the "Issuer").
These shares of common stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Third Amended and Restated 2007 Equity Incentive Plan (the "Plan") that vests in full on May 1, 2014; however, delivery of the shares is deferred until the earlier of (a) three years from the date of grant and (b) the date of the director's separation from service to the Issuer.
Grant of stock option pursuant to the Plan. This option vests and becomes exercisable in twenty-four equal monthly installments over two years from the date of grant.
Grant of stock option pursuant to the Plan. This option vests and becomes exercisable in full on May 1, 2014.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. AMAG Pharmaceuticals next reports earnings on April 21, 2014.
To receive a free e-mail notification whenever AMAG Pharmaceuticals makes a similar move, sign up!